Sab Biotherapeutics Stock Bond Positions Weight
SABSW Stock | USD 0.10 0.01 17.65% |
SAB Biotherapeutics fundamentals help investors to digest information that contributes to SAB Biotherapeutics' financial success or failures. It also enables traders to predict the movement of SAB Stock. The fundamental analysis module provides a way to measure SAB Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SAB Biotherapeutics stock.
SAB | Bond Positions Weight |
SAB Biotherapeutics Company Bond Positions Weight Analysis
SAB Biotherapeutics' Percentage of fund asset invested in fixed income securities. About 30% of U.S. mutual funds invest in bonds.
SAB Bond Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for SAB Biotherapeutics is extremely important. It helps to project a fair market value of SAB Stock properly, considering its historical fundamentals such as Bond Positions Weight. Since SAB Biotherapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of SAB Biotherapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of SAB Biotherapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Funds that have over 60% of asset value invested in bonds or or other fixed income securities would usually attract conservative investors.
Competition |
In accordance with the recently published financial statements, SAB Biotherapeutics has a Bond Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
SAB Fundamentals
Return On Equity | -1.75 | ||||
Return On Asset | -0.79 | ||||
Operating Margin | (34.23) % | ||||
Number Of Shares Shorted | 1.71 K | ||||
Price To Earning | 0.21 X | ||||
Revenue | 2.24 M | ||||
EBITDA | (38.13 M) | ||||
Net Income | (42.19 M) | ||||
Total Debt | 5.91 M | ||||
Book Value Per Share | 4.00 X | ||||
Cash Flow From Operations | (25.12 M) | ||||
Earnings Per Share | 0.29 X | ||||
Number Of Employees | 57 | ||||
Beta | 0.64 | ||||
Total Asset | 83.94 M | ||||
Retained Earnings | (90.06 M) | ||||
Working Capital | 48.09 M | ||||
Net Asset | 83.94 M |
About SAB Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SAB Biotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SAB Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SAB Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Additional Tools for SAB Stock Analysis
When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.